4 hours Syros Pharmaceuticals (NASDAQ:SYRS) Downgraded by StockNews.com MarketBeat
StockNews.com cut Syros Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Monday.
Nasdaq 100 · Pharmaceuticals · Science
StockNews.com cut Syros Pharmaceuticals from a “hold” rating to a “sell” rating in a research report on Monday.
Nasdaq 100 · Pharmaceuticals · Science